CLINICAL TRIAL
JOURNAL ARTICLE
MULTICENTER STUDY
RANDOMIZED CONTROLLED TRIAL
Add like
Add dislike
Add to saved papers

Risk of stroke in the distribution of an asymptomatic carotid artery. The European Carotid Surgery Trialists Collaborative Group.

Lancet 1995 January 29
Screening and carotid endarterectomy have been advocated for asymptomatic carotid stenosis. However, the risk of stroke without treatment has not been adequately defined. We investigated the risk of stroke in the distribution of the asymptomatic carotid artery in 2295 patients randomised in the European Carotid Surgery Trial. During a mean follow-up of 4.5 years, there were 69 carotid territory strokes, nine of which were fatal, giving three year Kaplan-Meier risks of stroke and fatal stroke of 2.1% (95% Cl, 1.5-2.8) and 0.3% (95% Cl, 0.06-0.56) respectively. The stroke risk in the 127 patients with severe (70-99%) carotid stenosis was 5.7% (95% Cl, 1.5-9.8). Given these low stroke risks, the potential benefit of endarterectomy for asymptomatic carotid stenosis is small. Population screening is not justified and endarterectomy for asymptomatic carotid stenosis should only be performed in the context of well organised randomised controlled trials.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app